cyclopentane has been researched along with Myocardial Infarction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, NC; Lee, TM; Lin, SZ | 1 |
| Deschamps, AM; Murphy, E | 1 |
2 other study(ies) available for cyclopentane and Myocardial Infarction
| Article | Year |
|---|---|
Both GPER and membrane oestrogen receptor-α activation protect ventricular remodelling in 17β oestradiol-treated ovariectomized infarcted rats.
Topics: Animals; Blotting, Western; Cyclopentanes; Estradiol; Estrogen Receptor alpha; Estrogens; Female; Ginsenosides; Membrane Proteins; Myocardial Infarction; Nitric Oxide Synthase Type III; Ovariectomy; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Quinolines; Random Allocation; Rats, Wistar; Receptors, G-Protein-Coupled; Sapogenins; Signal Transduction; Ventricular Remodeling | 2014 |
Activation of a novel estrogen receptor, GPER, is cardioprotective in male and female rats.
Topics: Androstadienes; Animals; Cardiotonic Agents; Cyclopentanes; Disease Models, Animal; Female; In Vitro Techniques; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Myocardial Contraction; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Perfusion; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Quinolines; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Receptors, G-Protein-Coupled; Signal Transduction; Ventricular Function, Left; Ventricular Pressure; Wortmannin | 2009 |